BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 11448324)

  • 1. Unilateral or asymmetric pseudoexfoliation syndrome? An ultrastructural study.
    Hammer T; Schlötzer-Schrehardt U; Naumann GO
    Arch Ophthalmol; 2001 Jul; 119(7):1023-31. PubMed ID: 11448324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Unilateral or asymmetric PEX syndrome? An electron microscopy study].
    Hammer T; Schlötzer-Schrehardt U; Jünemann A
    Klin Monbl Augenheilkd; 2000 Aug; 217(2):100-8. PubMed ID: 11022664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunoelectron microscopic localization of the HNK-1 carbohydrate epitope in the anterior segment of pseudoexfoliation and normal eyes.
    Kubota T; Schlötzer-Schrehardt U; Inomata H; Naumann GO
    Curr Eye Res; 1997 Mar; 16(3):231-8. PubMed ID: 9088739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased extracellular deposition of fibrillin-containing fibrils in pseudoexfoliation syndrome.
    Schlötzer-Schrehardt U; von der Mark K; Sakai LY; Naumann GO
    Invest Ophthalmol Vis Sci; 1997 Apr; 38(5):970-84. PubMed ID: 9112993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. "Masked" pseudoexfoliation syndrome in unoperated eyes with circular posterior synechiae: clinical-electron microscopic correlation.
    Mardin CY; Schlötzer-Schrehardt U; Naumann GO
    Arch Ophthalmol; 2001 Oct; 119(10):1500-3. PubMed ID: 11594951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clusterin deficiency in eyes with pseudoexfoliation syndrome may be implicated in the aggregation and deposition of pseudoexfoliative material.
    Zenkel M; Kruse FE; Jünemann AG; Naumann GO; Schlötzer-Schrehardt U
    Invest Ophthalmol Vis Sci; 2006 May; 47(5):1982-90. PubMed ID: 16639006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of transforming growth factor-beta1 and its latent form binding protein in pseudoexfoliation syndrome.
    Schlötzer-Schrehardt U; Zenkel M; Küchle M; Sakai LY; Naumann GO
    Exp Eye Res; 2001 Dec; 73(6):765-80. PubMed ID: 11846508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trabecular meshwork in pseudoexfoliation syndrome with and without open-angle glaucoma. A morphometric, ultrastructural study.
    Schlötzer-Schrehardt U; Naumann GO
    Invest Ophthalmol Vis Sci; 1995 Aug; 36(9):1750-64. PubMed ID: 7635652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Relevance of the pseudoexfoliation syndrome for the glaucomas].
    Schlötzer-Schrehardt U; Küchle M; Jünemann A; Naumann GO
    Ophthalmologe; 2002 Sep; 99(9):683-90. PubMed ID: 12219256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Latent TGF-beta 1 binding protein (LTBP-1); a new marker for intra-and extraocular PEX deposits].
    Schlötzer-Schrehardt U; Küchle M; Hofmann-Rummelt C; Kaiser A; Kirchner T
    Klin Monbl Augenheilkd; 2000 Jun; 216(6):412-9. PubMed ID: 10919121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A histopathologic study of iris changes in pseudoexfoliation syndrome.
    Asano N; Schlötzer-Schrehardt U; Naumann GO
    Ophthalmology; 1995 Sep; 102(9):1279-90. PubMed ID: 9097764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Age-dependent iris abnormalities in collagen XVIII/endostatin deficient mice with similarities to human pigment dispersion syndrome.
    Marneros AG; Olsen BR
    Invest Ophthalmol Vis Sci; 2003 Jun; 44(6):2367-72. PubMed ID: 12766032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anterior segment optical coherence tomography analysis of clinically unilateral pseudoexfoliation syndrome: evidence of bilateral involvement and morphologic factors related to asymmetry.
    Zheng X; Sakai H; Goto T; Namiguchi K; Mizoue S; Shiraishi A; Sawaguchi S; Ohashi Y
    Invest Ophthalmol Vis Sci; 2011 Jul; 52(8):5679-84. PubMed ID: 21540476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ultrastructural analysis of the pigment dispersion syndrome in DBA/2J mice.
    Schraermeyer M; Schnichels S; Julien S; Heiduschka P; Bartz-Schmidt KU; Schraermeyer U
    Graefes Arch Clin Exp Ophthalmol; 2009 Nov; 247(11):1493-504. PubMed ID: 19641932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distribution and characterization of proteoglycans associated with exfoliation material.
    Tawara A; Fujisawa K; Kiyosawa R; Inomata H
    Curr Eye Res; 1996 Nov; 15(11):1101-11. PubMed ID: 8950504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blood-aqueous barrier in pseudoexfoliation syndrome: evaluation by immunohistochemical staining of endogenous albumin.
    Küchle M; Vinores SA; Mahlow J; Green WR
    Graefes Arch Clin Exp Ophthalmol; 1996 Jan; 234(1):12-8. PubMed ID: 8750845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autopsy analysis of clinically unilateral exfoliation syndrome.
    Kivelä T; Hietanen J; Uusitalo M
    Invest Ophthalmol Vis Sci; 1997 Sep; 38(10):2008-15. PubMed ID: 9331264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HNK-1 epitope in the lens-ciliary zonular region in normal and pseudoexfoliative eyes. Immunohistochemistry and ultrastructure.
    Qi Y; Streeten BW; Wallace RN
    Arch Ophthalmol; 1997 May; 115(5):637-44. PubMed ID: 9152132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential gene expression in pseudoexfoliation syndrome.
    Zenkel M; Pöschl E; von der Mark K; Hofmann-Rummelt C; Naumann GO; Kruse FE; Schlötzer-Schrehardt U
    Invest Ophthalmol Vis Sci; 2005 Oct; 46(10):3742-52. PubMed ID: 16186358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pseudoexfoliation syndrome for the comprehensive ophthalmologist. Intraocular and systemic manifestations.
    Naumann GO; Schlötzer-Schrehardt U; Küchle M
    Ophthalmology; 1998 Jun; 105(6):951-68. PubMed ID: 9627642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.